ACESION PHARMA ApS: Financial statements 2013
CVR: 34083738
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -4,833,419 and a net result of DKK -6,507,161 compared with DKK -2,068,513 the year before. Equity in the 2013 report amounted to DKK -555,682.
- Gross Profit
- DKK -4,833,419
- Profit/Loss
- DKK -6,507,161
- Equity
- DKK -555,682
- Total Assets
- DKK 9,056,025
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
| 2012 | - | -1.3 mio. | -2.1 mio. | 2 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ACESION PHARMA ApS has published its annual report for 2012. Gross profit came to DKK -1,313,935, and the net result was DKK -2,068,513.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.